Patents by Inventor Ki Duk Park

Ki Duk Park has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11917875
    Abstract: A display device includes a substrate including an active area having pixels and a non-active area including a pad region. A pad electrode is disposed in the pad region and includes a first pad electrode and a second pad electrode disposed on the first pad electrode. A first insulating pattern is interposed between the first and second pad electrodes. In a plan view, the first insulating pattern is positioned inside the first pad electrode, and a portion of the second pad electrode overlapping the first insulating pattern protrudes further from the substrate in a thickness direction than a portion of the second pad electrode not overlapping the first insulating pattern. The second pad electrode directly contacts a portion of the upper surface of the first pad electrode. In a plan view, an area of the second pad electrode is greater than an area of the first pad electrode.
    Type: Grant
    Filed: December 29, 2021
    Date of Patent: February 27, 2024
    Assignee: SAMSUNG DISPLAY CO., LTD.
    Inventors: Ki Kyung Youk, Chan Jae Park, Min Soo Kim, Yoon A Kim, Sang Duk Lee, Chel Gou Lim
  • Publication number: 20230406812
    Abstract: The present invention provides a novel aminoaromatic compound or a pharmaceutically acceptable salt thereof, a pharmaceutical composition that is for preventing or treating neurodegenerative diseases and comprises same as an active ingredient, and a health functional food composition for preventing or ameliorating neurodegenerative diseases.
    Type: Application
    Filed: November 12, 2021
    Publication date: December 21, 2023
    Inventors: Chang Jun LEE, Heejung CHUN, Woojin WON, Ki Duk PARK, Jong Hyun PARK, Ae Nim PAE, Ji Won CHOI, Elijah LEE, Sun Jun PARK, Hyeon Jeong KIM, Yoowon KIM, Byung Eun KIM, Siwon KIM
  • Publication number: 20230129819
    Abstract: The present invention relates to a preparation method for an animal model with Alzheimer's disease by injecting a human mutant tau (AAV-hTau) vector and adenovirus into an animal. The preparation method for an AD animal model provided by the present invention may contribute to the development of the field of treatment technology for treating AD since the preparation method causes AD pathology to appear as early as 8 months old and facilitates studies on AD target treatment strategies and tau pathology.
    Type: Application
    Filed: October 25, 2022
    Publication date: April 27, 2023
    Applicant: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
    Inventors: Soo-Jin OH, Sunhwa LIM, Min-Ho NAM, Ki Duk PARK, Seung Eun LEE
  • Publication number: 20230067422
    Abstract: The present invention relates to a derivative compound in which a biphenyl group is introduced into an aminoalkanoic acid, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof. The compound of the present invention exhibits excellent antifungal and fungicidal effects. Furthermore, the compound of the present invention exhibits a synergistic effect when used in combination with a conventional antifungal agent. Furthermore, the compound of the present invention provides broad-spectrum antifungal activity against a wide range of fungal pathogens. Therefore, the compound of the present invention may be widely used in fields requiring treatment with antifungal or fungicidal agents against human pathogenic fungi and animal pathogenic fungi, and phytopathogenic fungi.
    Type: Application
    Filed: September 19, 2022
    Publication date: March 2, 2023
    Inventors: Ki Duk PARK, Jong Hyun PARK, Hyeon Ji KIM, Ye Rim LEE, Siwon KIM, Ji Won CHOI, Seul Ki YEON, Jong-Seung LEE, Yong-Sun BAHN, Eunji CHEONG, Kyung-Tae LEE, Joohyeon HONG
  • Publication number: 20230056812
    Abstract: The present invention relates to a derivative compound in which a biphenyl group is introduced into an aminoalkanoic acid, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof. The compound of the present invention exhibits excellent antifungal and fungicidal effects. Furthermore, the compound of the present invention exhibits a synergistic effect when used in combination with a conventional antifungal agent. Furthermore, the compound of the present invention provides broad-spectrum antifungal activity against a wide range of fungal pathogens. Therefore, the compound of the present invention may be widely used in fields requiring treatment with antifungal or fungicidal agents against human pathogenic fungi and animal pathogenic fungi, and phytopathogenic fungi.
    Type: Application
    Filed: September 19, 2022
    Publication date: February 23, 2023
    Inventors: Ki Duk PARK, Jong Hyun PARK, Hyeon Ji KIM, Ye Rim LEE, Siwon KIM, Ji Won CHOI, Seul Ki YEON, Jong-Seung LEE, Yong-Sun BAHN, Eunji CHEONG, Kyung-Tae LEE, Joohyeon HONG
  • Publication number: 20230053855
    Abstract: The present invention relates to a derivative compound in which a biphenyl group is introduced into an aminoalkanoic acid, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof. The compound of the present invention exhibits excellent antifungal and fungicidal effects. Furthermore, the compound of the present invention exhibits a synergistic effect when used in combination with a conventional antifungal agent. Furthermore, the compound of the present invention provides broad-spectrum antifungal activity against a wide range of fungal pathogens. Therefore, the compound of the present invention may be widely used in fields requiring treatment with antifungal or fungicidal agents against human pathogenic fungi and animal pathogenic fungi, and phytopathogenic fungi.
    Type: Application
    Filed: September 19, 2022
    Publication date: February 23, 2023
    Inventors: Ki Duk PARK, Jong Hyun PARK, Hyeon Ji KIM, Ye Rim LEE, Siwon KIM, Ji Won CHOI, Seul Ki YEON, Jong-Seung LEE, Yong-Sun BAHN, Eunji CHEONG, Kyung-Tae LEE, Joohyeon HONG
  • Patent number: 11479526
    Abstract: The present invention relates to a derivative compound in which a biphenyl group is introduced into an aminoalkanoic acid, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof. The compound of the present invention exhibits excellent antifungal and fungicidal effects. Furthermore, the compound of the present invention exhibits a synergistic effect when used in combination with a conventional antifungal agent. Furthermore, the compound of the present invention provides broad-spectrum antifungal activity against a wide range of fungal pathogens. Therefore, the compound of the present invention may be widely used in fields requiring treatment with antifungal or fungicidal agents against human pathogenic fungi and animal pathogenic fungi, and phytopathogenic fungi.
    Type: Grant
    Filed: December 27, 2021
    Date of Patent: October 25, 2022
    Assignee: AMTIXBIO CO., LTD.
    Inventors: Ki Duk Park, Jong Hyun Park, Hyeon Ji Kim, Ye Rim Lee, Siwon Kim, Ji Won Choi, Seul Ki Yeon, Jong-Seung Lee, Yong-Sun Bahn, Eunji Cheong, Kyung-Tae Lee, Joohyeon Hong
  • Publication number: 20220144755
    Abstract: The present invention relates to a derivative compound in which a biphenyl group is introduced into an aminoalkanoic acid, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof. The compound of the present invention exhibits excellent antifungal and fungicidal effects. Furthermore, the compound of the present invention exhibits a synergistic effect when used in combination with a conventional antifungal agent. Furthermore, the compound of the present invention provides broad-spectrum antifungal activity against a wide range of fungal pathogens. Therefore, the compound of the present invention may be widely used in fields requiring treatment with antifungal or fungicidal agents against human pathogenic fungi and animal pathogenic fungi, and phytopathogenic fungi.
    Type: Application
    Filed: December 27, 2021
    Publication date: May 12, 2022
    Inventors: Ki Duk PARK, Jong Hyun Park, Hyeon Ji Kim, Ye Rim Lee, Siwon Kim, Ji Won Choi, Seul Ki Yeon, Jong-Seung Lee, Yong-Sun Bahn, Eunji Cheong, Kyung-Tae Lee, Joohyeon Hong
  • Patent number: 11249662
    Abstract: A memory module includes a plurality of semiconductor memory devices associated with a same module board. The plurality of semiconductor memory devices configured to simultaneously perform a training operation, the plurality of semiconductor memory devices including a reception interface circuit configured to perform the training operation to search for selected equalization coefficients of an equalizer based on a training pattern from a memory controller, and transmit a training information signal to the memory controller in a training mode in response to a training command from the memory controller, the training information signal including the selected equalization coefficients.
    Type: Grant
    Filed: June 29, 2020
    Date of Patent: February 15, 2022
    Assignee: Samsung Electronics Co., Ltd.
    Inventors: Wang-Soo Kim, Jung-Hwan Choi, Ki-Duk Park, Yoo-Chang Sung, Jin-Sung Youn, Chang-Kyo Lee, Ju-Ho Jeon, Jin-Seok Heo
  • Publication number: 20210401782
    Abstract: The present invention relates to a pharmaceutical composition comprising (S)-2-(((4?-trifluoromethylbiphenyl-4-yl)methyl)amino)propanamide methanesulfonate or a pharmaceutically acceptable salt thereof as an effective ingredient for prevention or treatment of stroke.
    Type: Application
    Filed: April 1, 2019
    Publication date: December 30, 2021
    Applicant: NEUROBIOGEN CO.,LTD
    Inventors: Ki Duk PARK, Changjoon LEE, Soo-Jin OH, Ae Nim PAE, Sang Min LIM, Jong Hyun PARK, Min-Ho NAM, Hyoung Ihl KIM, Ji Young PARK, Jongwook CHO
  • Publication number: 20210317083
    Abstract: The present invention relates to a novel halo-(3-(phenylsulfonyl)prop-1-enyl)pyridine derivative or a pharmaceutically acceptable salt thereof; a preparation method thereof; and an Nrf2 activator and a pharmaceutical composition for preventing or treating diseases induced by a decrease in Nrf2 activity, both of which comprise the same as an active ingredient.
    Type: Application
    Filed: August 19, 2019
    Publication date: October 14, 2021
    Inventors: Ki Duk PARK, Ae Nim PAE, Sang Min LIM, Jong Hyun PARK, Ji Won CHOI, Siwon KIM, Hyeon Jeong KIM, Seul Ki YEON
  • Patent number: 11053190
    Abstract: The present disclosure relates to an ?-aminoamide derivative compound and a pharmaceutical composition containing the same. According to various embodiments of the present disclosure, provided is a therapeutic agent which can overcome the disadvantages of existing drugs used as a MAO-B inhibitor and, specifically, reversibly inhibits MAO-B through a non-covalent bond so as to alleviate or eliminate the side effects of the existing drugs which exhibit a therapeutic effect by irreversibly acting via a covalent bond with MAO-B. Particularly, a new compound having superior stability and efficacy compared to the existing reversible MAO-B inhibitors may be provided.
    Type: Grant
    Filed: April 24, 2020
    Date of Patent: July 6, 2021
    Assignee: NeuroBiogen Co., Ltd.
    Inventors: Ki Duk Park, ChangJoon Justin Lee, Dong Jin Kim, Ae Nim Pae, Hyun Ah Choo, Sun Joon Min, Yong Koo Kang, Yun Kyung Kim, Hyo Jung Song, Ji Won Choi, Min Ho Nam, Jun Young Heo, Seul Ki Yeon, Bo Ko Jang, Eun Ji Ju, Seon Mi Jo, Jong-Hyun Park
  • Publication number: 20210030700
    Abstract: The present invention relates to a pharmaceutical composition comprising (S)-2-(((4?-trifluoromethylbiphenyl-4-yl)methyl)amino)propanamide methanesulfonate or a pharmaceutically acceptable salt thereof as an effective ingredient for prevention or treatment of spinal cord injury.
    Type: Application
    Filed: February 7, 2019
    Publication date: February 4, 2021
    Applicant: NEUROBIOGEN CO.,LTD
    Inventors: Ki Duk PARK, Changjoon LEE, Ae Nim PAE, Soo-Jin OH, Sang Min LIM, Jong Hyun PARK, Jungmoo LEE, Yoon HA, Hye Yeong LEE
  • Publication number: 20200326865
    Abstract: A memory module includes a plurality of semiconductor memory devices associated with a same module board. The plurality of semiconductor memory devices configured to simultaneously perform a training operation, the plurality of semiconductor memory devices including a reception interface circuit configured to perform the training operation to search for selected equalization coefficients of an equalizer based on a training pattern from a memory controller, and transmit a training information signal to the memory controller in a training mode in response to a training command from the memory controller, the training information signal including the selected equalization coefficients.
    Type: Application
    Filed: June 29, 2020
    Publication date: October 15, 2020
    Applicant: Samsung Electronics Co., Ltd.
    Inventors: Wang-Soo KIM, Jung-Hwan CHOI, Ki-Duk PARK, Yoo-Chang SUNG, Jin-Sung YOUN, Chang-Kyo LEE, Ju-Ho JEON, Jin-Seok HEO
  • Publication number: 20200308104
    Abstract: The present disclosure relates to an ?-aminoamide derivative compound and a pharmaceutical composition containing the same. According to various embodiments of the present disclosure, provided is a therapeutic agent which can overcome the disadvantages of existing drugs used as a MAO-B inhibitor and, specifically, reversibly inhibits MAO-B through a non-covalent bond so as to alleviate or eliminate the side effects of the existing drugs which exhibit a therapeutic effect by irreversibly acting via a covalent bond with MAO-B. Particularly, a new compound having superior stability and efficacy compared to the existing reversible MAO-B inhibitors may be provided.
    Type: Application
    Filed: April 24, 2020
    Publication date: October 1, 2020
    Inventors: Ki Duk PARK, ChangJoon Justin LEE, Dong Jin KIM, Ae Nim PAE, Hyun Ah CHOO, Sun Joon MIN, Yong Koo KANG, Yun Kyung KIM, Hyo Jung SONG, Ji Won CHOI, Min Ho NAM, Jun Young HEO, Seul Ki YEON, Bo Ko JANG, Eun Ji JU, Seon Mi JO, Jong-Hyun PARK
  • Patent number: 10725682
    Abstract: A memory module includes a plurality of semiconductor memory devices associated with a same module board. The plurality of semiconductor memory devices configured to simultaneously perform a training operation, the plurality of semiconductor memory devices including a reception interface circuit configured to perform the training operation to search for selected equalization coefficients of an equalizer based on a training pattern from a memory controller, and transmit a training information signal to the memory controller in a training mode in response to a training command from the memory controller, the training information signal including the selected equalization coefficients.
    Type: Grant
    Filed: August 14, 2018
    Date of Patent: July 28, 2020
    Assignee: Samsung Electronics Co., Ltd.
    Inventors: Wang-Soo Kim, Jung-Hwan Choi, Ki-Duk Park, Yoo-Chang Sung, Jin-Sung Youn, Chang-Kyo Lee, Ju-Ho Jeon, Jin-Seok Heo
  • Publication number: 20200199065
    Abstract: The present invention relates to novel functional derivatives of alanine and proline amino acids. The compounds of the present invention were confirmed to have a very superior antifungal or fungicidal effect. In addition, the compounds of the present invention were confirmed to exhibit a synergistic effect when co-administered with an existing antifungal preparation. Moreover, the compounds of the present invention showed activity on a wide range of fungi. Therefore, the compounds of the present invention can be widely used in a field which requires the treatment with an antifungal or fungicidal preparation against human infectious fungi, animal infectious fungi, and phytopathogenic fungi.
    Type: Application
    Filed: October 30, 2017
    Publication date: June 25, 2020
    Inventors: Ki Duk Park, Yong-Sun Bahn, Jong-Seung Lee, Kyung-Tae Lee, Ae Nim Pae, Seul Ki Yeon, Yong Koo Kang, Jong Hyun Park, Siwon Kim, Bo Ko Jang, Ji Won Choi
  • Patent number: 10676425
    Abstract: The present disclosure relates to an ?-aminoamide derivative compound and a pharmaceutical composition containing the same, for treating a neurodegenerative diseases.
    Type: Grant
    Filed: September 24, 2015
    Date of Patent: June 9, 2020
    Assignee: MEGABIOWOOD CO., LTD
    Inventors: Ki Duk Park, ChangJoon Justin Lee, Dong Jin Kim, Ae Nim Pae, Hyun Ah Choo, Sun Joon Min, Yong Koo Kang, Yun Kyung Kim, Hyo Jung Song, Ji Won Choi, Min Ho Nam, Jun Young Heo, Seul Ki Yeon, Bo Ko Jang, Eun Ji Ju, Seon Mi Jo, Jong-Hyun Park
  • Publication number: 20190179553
    Abstract: A memory module includes a plurality of semiconductor memory devices associated with a same module board. The plurality of semiconductor memory devices configured to simultaneously perform a training operation, the plurality of semiconductor memory devices including a reception interface circuit configured to perform the training operation to search for selected equalization coefficients of an equalizer based on a training pattern from a memory controller, and transmit a training information signal to the memory controller in a training mode in response to a training command from the memory controller, the training information signal including the selected equalization coefficients.
    Type: Application
    Filed: August 14, 2018
    Publication date: June 13, 2019
    Applicant: Samsung Electronics Co., Ltd.
    Inventors: Wang-Soo Kim, Jung-Hwan Choi, Ki-Duk Park, Yoo-Chang Sung, Jin-Sung Youn, Chang-Kyo Lee, Ju-Ho Jeon, Jin-Seok Heo
  • Publication number: 20170298011
    Abstract: The present disclosure relates to an ?-aminoamide derivative compound and a pharmaceutical composition containing the same. According to various embodiments of the present disclosure, provided is a therapeutic agent which can overcome the disadvantages of existing drugs used as a MAO-B inhibitor and, specifically, reversibly inhibits MAO-B through a non-covalent bond so as to alleviate or eliminate the side effects of the existing drugs which exhibit a therapeutic effect by irreversibly acting via a covalent bond with MAO-B. Particularly, a new compound having superior stability and efficacy compared to the existing reversible MAO-B inhibitors may be provided.
    Type: Application
    Filed: September 24, 2015
    Publication date: October 19, 2017
    Inventors: Ki Duk PARK, ChangJoon Justin LEE, Dong Jin KIM, Ae Nim PAE, Hyun Ah CHOO, Sun Joon MIN, Yong Koo KANG, Yun Kyung KIM, Hyo Jung SONG, Ji Won CHOI, Min Ho NAM, Jun Young HEO, Seul Ki YEON, Bo Ko JANG, Eun Ji JU, Seon Mi JO, Jong-Hyun PARK